CPRX Catalyst Pharmaceuticals, Inc.
Healthcare · Biotechnology
92.4%
Forte
13/14 critérios · 5a dados
Dados de Mercado
- P/L (Forward)
- 7.5
- P/L (Trailing)
- 13.9
- P/VP
- 2.99
- Market Cap
- $2.9B
- Enterprise Value
- $2.1B
Último Ano Fiscal
Dec 2025
- Receita
- $589.0M
- EBIT
- $257.8M
- EBITDA
- $295.7M
- FCO
- $208.7M
- FCF
- $208.6M
Histórico Anual
| Ano | Receita | EBIT | EBITDA | FCO | FCF |
|---|---|---|---|---|---|
| 2021 | — | — | — | — | — |
| 2022 | $214.2M | $101.8M | $103.1M | $116.0M | $116.0M |
| 2023 | $398.2M | $86.8M | $119.7M | $143.6M | $61.9M |
| 2024 | $491.7M | $195.1M | $232.9M | $239.8M | $239.3M |
| 2025 | $589.0M | $257.8M | $295.7M | $208.7M | $208.6M |
Quer uma análise mais profunda?
Nossos clientes recebem análises completas com valuation, tese de investimento e acompanhamento contínuo.
Falar com Especialista